PKD FOUNDATION for PKD FOUNDATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2011 | $20,000 | Replaced |
| 4th Quarter - Termination Amendment | Dec 17, 2012 | $20,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Seeking co-sponsorship for and passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CANTOR | — |
Budget/Appropriations BUD
Report language to the FY 2011 Labor-Health and Human Services-Education Appropriations Act supporting PKD research at the National Institute of Diabetes, Digestive and Kidney Disease (NIDDK); support for increasing overall funding for the National Institutes of Health (NIH)
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CANTOR | — |
| DAN E LARSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.